Practice management in the era of anti-VEGF therapy (Part I)

Article

Identifying the bottlenecks that are preventing effective management of neovascular AMD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Related Content
A young person with short androgynous hair sits in a waiting room, looking thoughtful. Concept image for racial groups in clinical trials and representation in studies. Image credit: ©wayhome.studio – stock.adobe.com

DMO study meta-analysis illuminates how racial subgroups are underrepresented in clinical trials

Lynda Charters
April 17th 2025
Article

The study aimed to clarify how race affects visual outcomes for patients with diabetic macular oedema treated with ranibizumab

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

An image which shows a translucent head, with the eye, brain and optic nerve highlighted. Concept for brain-eye neurology neuroinflammation connection. Image credit: ©jitendra jadhav – stock.adobe.com

Journal of Neuroinflammation publishes data on Eleva’s lead retinal asset CPV-104

Sydney M Crago
April 16th 2025
Article

In an established animal model of age-related macular degeneration, Eleva’s recombinant human CPV-104 improved two hallmarks of the disease

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A scientist in a lab looks into a microscope, which is placed on a desk. His face is not fully visible but he wears a lab coat and sits in front of a computer. Concept image for cell therapy, stem cell research, phase 1 clinical trial, and geographic atrophy associated with age-related macular degeneration. Image credit: ©CoetzeeRising/peopleimages.com – stock.adobe.com

Eyestem Research announces positive results from phase 1 geographic atrophy trial

Martin David Harp
April 14th 2025
Article

Bangalore-based Eyestem will share more research findings on Eyecyte-RPE at this year's Association for Research in Vision and Ophthalmology meeting

Site Logo

A Turning Point in Retinal Neovascular Diseases

Sponsored by Bayer
April 11th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.